Lloyd PM - Search Results

1

Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation.

Rabinowitz JD, Lloyd PM, Munzar P, Myers DJ, Cross S, Damani R, Quintana R, Spyker DA, Soni P, Cassella JV. Rabinowitz JD, et al. Among authors: lloyd pm. J Pharm Sci. 2006 Nov;95(11):2438-51. doi: 10.1002/jps.20694. J Pharm Sci. 2006. PMID: 16886198 Clinical Trial.

2

Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs.

Avram MJ, Henthorn TK, Spyker DA, Krejcie TC, Lloyd PM, Cassella JV, Rabinowitz JD. Avram MJ, et al. Among authors: lloyd pm. Drug Metab Dispos. 2007 Feb;35(2):262-7. doi: 10.1124/dmd.106.010652. Epub 2006 Nov 1. Drug Metab Dispos. 2007. PMID: 17079359

3

Fast onset medications through thermally generated aerosols.

Rabinowitz JD, Wensley M, Lloyd P, Myers D, Shen W, Lu A, Hodges C, Hale R, Mufson D, Zaffaroni A. Rabinowitz JD, et al. J Pharmacol Exp Ther. 2004 May;309(2):769-75. doi: 10.1124/jpet.103.062893. Epub 2004 Jan 29. J Pharmacol Exp Ther. 2004. PMID: 14752061 Free article.

4

The AERX aerosol delivery system.

Schuster J, Rubsamen R, Lloyd P, Lloyd J. Schuster J, et al. Pharm Res. 1997 Mar;14(3):354-7. doi: 10.1023/a:1012058323754. Pharm Res. 1997. PMID: 9098880

5

Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431.

Okumu FW, Lee RY, Blanchard JD, Queirolo A, Woods CM, Lloyd PM, Okikawa J, Gonda I, Farr SJ, Rubsamen R, Adjei AL, Bertz RJ. Okumu FW, et al. Among authors: lloyd pm. Pharm Res. 2002 Jul;19(7):1009-12. doi: 10.1023/a:1016559707084. Pharm Res. 2002. PMID: 12180532 Clinical Trial.

6

Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.

Ward ME, Woodhouse A, Mather LE, Farr SJ, Okikawa JK, Lloyd P, Schuster JA, Rubsamen RM. Ward ME, et al. Clin Pharmacol Ther. 1997 Dec;62(6):596-609. doi: 10.1016/S0009-9236(97)90079-5. Clin Pharmacol Ther. 1997. PMID: 9433388

7

Inhalation delivery systems with compliance and disease management capabilities.

Gonda I, Schuster JA, Rubsamen RM, Lloyd P, Cipolla D, Farr SJ. Gonda I, et al. J Control Release. 1998 Apr 30;53(1-3):269-74. doi: 10.1016/s0168-3659(97)00260-5. J Control Release. 1998. PMID: 9741934

8

Design and testing of aerosol delivery systems for reproducible clinical performance.

Cipolla DC, Farr SJ, Gonda I, Herst CV, Lee RY, Lloyd P, McKinley G, Rubsamen R, Schuster J, Zellhoefer C. Cipolla DC, et al. J Aerosol Med. 1998;11 Suppl 1:S84-8. J Aerosol Med. 1998. PMID: 10180738 No abstract available.

9

Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler.

Farr SJ, Warren SJ, Lloyd P, Okikawa JK, Schuster JA, Rowe AM, Rubsamen RM, Taylor G. Farr SJ, et al. Int J Pharm. 2000 Mar 30;198(1):63-70. doi: 10.1016/s0378-5173(99)00452-4. Int J Pharm. 2000. PMID: 10722951 Clinical Trial.

10

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.

Herst CV, Burkholz S, Sidney J, Sette A, Harris PE, Massey S, Brasel T, Cunha-Neto E, Rosa DS, Chao WCH, Carback R, Hodge T, Wang L, Ciotlos S, Lloyd P, Rubsamen R. Herst CV, et al. Vaccine. 2020 Jun 9;38(28):4464-4475. doi: 10.1016/j.vaccine.2020.04.034. Epub 2020 Apr 28. Vaccine. 2020. PMID: 32418793 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page